Every year millions of the world’s poorest people die from curable or preventable infectious diseases or suffer unnecessary ill health because they do not have access to basic health care services, including essential medicines and vaccines. The reasons for this are complex and plentiful....but these problems cannot be an excuse for inaction, writes Andrew Witty, CEO of GlaxoSmithKline.
The threat is no longer low-cost manufacturing; it’s high-tech and ideas. And the proof? As of this year, China has overtaken Germany as the world’s biggest exporter. And it’s not limited to less expensive products.
I have always advocated for investment in engineering – to both improve society and stimulate economies. It’s true that as engineer myself I have a vested interest. But following the financial fallout this is no longer just a point of view. It’s a necessity, writes Sir James Dyson.
One major bank's recent announcement that it will boost base pay while reducing bonus opportunities for certain employees spawned headlines around the globe, and with good reason.
CNBC viewers share their memories of CNBC Chief Commentator Bill Seidman.
CNBC Anchor Bill Griffeth shares memories of Bill Seidman that reflect on the special character of the former FDIC chairman and CNBC chief commentator.
Under the new "bailout" — "rescue" — legislation, Treasury will be purchasing billions of dollars of mortgage-backed securities — mostly backed by subprime mortgages.
Aureus Asset Management CEO Karen Firestone says there's value in U.S.-centric consumer and health-care stocks.
U.S. sovereign bonds saw further gains on Wednesday ahead of some key data releases that could offer hints on the timing on an interest rate rise.
U.S. stock index futures indicated a higher open on Wednesday after the worst start to September in 13 years as China and rate hike fears dominated.
Despite international headwinds, U.S. and European strength could provide some equities buying opportunities, experts said.